Simpson M D, Jenner P, Marsden C D
Biochem Pharmacol. 1986 Oct 1;35(19):3203-8. doi: 10.1016/0006-2952(86)90414-4.
We have investigated the effect of single injections (1 mg/animal i.v.) of prolactin or vehicle, and repeated depot (0.125-1.0 mg/animal/day) or bolus (1.0 mg/animal/day) administration of prolactin or vehicle for 6 days to adult male rats. The density (Bmax) and affinity (Kd) of specific striatal [3H]spiperone binding was not changed by any of the prolactin treatment schedules used. Allogeneic transplants of anterior pituitary glands resulted in an increased concentration of circulating prolactin but did not alter the density or affinity of specific striatal [3H]spiperone binding in male rats, measured 2 weeks following the operation. Prolactin did not displace specific striatal [3H]spiperone binding when incorporated in vitro. Any effect of prolactin on striatal dopamine receptor function appears to be exerted only by high, non-physiological concentrations, and such effects are difficult to reproduce.
我们研究了单次注射(每只动物静脉注射1毫克)催乳素或赋形剂,以及对成年雄性大鼠连续6天重复给予长效(每只动物每天0.125 - 1.0毫克)或大剂量(每只动物每天1.0毫克)催乳素或赋形剂的效果。所采用的任何催乳素治疗方案均未改变纹状体特异性[³H]司哌罗宁结合的密度(Bmax)和亲和力(Kd)。垂体前叶的同种异体移植导致循环催乳素浓度升高,但在手术后2周测量时,并未改变雄性大鼠纹状体特异性[³H]司哌罗宁结合的密度或亲和力。在体外实验中,催乳素不会取代纹状体特异性[³H]司哌罗宁结合。催乳素对纹状体多巴胺受体功能的任何影响似乎仅在高浓度、非生理浓度下才会发挥作用,而且这种影响很难重现。